Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Change in Cash (2019 - 2025)

Quantum Biopharma's Change in Cash history spans 5 years, with the latest figure at $1.5 million for Q4 2025.

  • On a quarterly basis, Change in Cash fell 49.25% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.1 million, a 520.31% decrease, with the full-year FY2025 number at -$4.1 million, down 226.3% from a year prior.
  • Change in Cash hit $1.5 million in Q4 2025 for Quantum Biopharma, up from -$1.1 million in the prior quarter.
  • Over the last five years, Change in Cash for QNTM hit a ceiling of $2.9 million in Q4 2024 and a floor of -$6.7 million in Q1 2022.
  • Historically, Change in Cash has averaged -$1.2 million across 3 years, with a median of -$1.1 million in 2025.
  • The widest YoY moves for Change in Cash: up 49.25% in 2025, down 464.13% in 2025.
  • Tracing QNTM's Change in Cash over 3 years: stood at -$6.7 million in 2022, then skyrocketed by 143.01% to $2.9 million in 2024, then crashed by 49.25% to $1.5 million in 2025.
  • Business Quant data shows Change in Cash for QNTM at $1.5 million in Q4 2025, -$1.1 million in Q3 2025, and -$2.0 million in Q2 2025.